Ana M. González-Angulo
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, PI3K/AKT/mTOR signaling in cancer, Cancer Genomics and Diagnostics
Most-Cited Works
- → Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer(2008)2,876 cited
- → A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer(2007)1,609 cited
- → PD-L1 Expression in Triple-Negative Breast Cancer(2014)1,378 cited
- → An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer(2008)1,033 cited
- → Overview of Resistance to Systemic Therapy in Patients with Breast Cancer(2007)913 cited
- → Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer(2009)874 cited
- → Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline(2016)810 cited
- → Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes(2013)707 cited
- → Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer(2014)650 cited
- → Targeting the mTOR Signaling Network for Cancer Therapy(2009)642 cited